未登录 Safety and efficacy of three PARP inhibitors (PARPi) combined with the ataxia telangiectasia- and Rad3-related kinase inhibitor (ATRi) camonsertib in patients (pts) with solid tumors harboring DNA damage response (DDR) alterations Yap, Timothy A.; Yadav, Siddhartha; Herzberg, Benjamin; Carneiro, Benedito A.; Fontana, Elisa; Hojgaard, Martin; Pishvaian, Michael J.; Plummer, Ruth; Werner, Theresa L.; Sahai, Vaibhav; Lheureux, Stephanie; Lee, Elizabeth K.; Mettu, Niharika B.; Cote, Gregory M.; Schonhoft, Joseph D.; Rimkunas, Victoria; Silverman, Ian M.; Wainszelbaum, Marisa; Peltz, Gerson; Fretland, Adrian J.; Fei, Kezhen; Ulanet, Danielle; Kim, Insil; Koehler, Maria; Rosen, Ezra; Cecchini, Michael 分享 收藏
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results Goldsmith, Kelly C.; Park, Julie R.; Kayser, Kimberly; Malvar, Jemily; Chi, Yueh-Yun; Groshen, Susan G.; Villablanca, Judith G.; Krytska, Kateryna; Lai, Lillian M.; Acharya, Patricia T.; Goodarzian, Fariba; Pawel, Bruce; Shimada, Hiroyuki; Ghazarian, Susan; States, Lisa; Marshall, Lynley; Chesler, Louis; Granger, Meaghan; Desai, Ami V.; Mody, Rajen; Morgenstern, Daniel A.; Shusterman, Suzanne; Macy, Margaret E.; Pinto, Navin; Schleiermacher, Gudrun; Vo, Kieuhoa; Thurm, Holger C.; Chen, Joseph; Liyanage, Marlon; Peltz, Gerson; Matthay, Katherine K.; Berko, Esther R.; Maris, John M.; Marachelian, Araz; Mosse, Yael P. 分享 收藏
First-Line Lorlatinib Versus Crizotinib in ALK-Positive NSCLC: Japanese Subgroup Analysis of CROWN Hayashi, Hidetoshi; Teraoka, Shunsuke; Goto, Yasushi; Kumagai, Toru; Nishio, Makoto; Sugawara, Shunichi; Oizumi, Satoshi; Matsumura, Masakazu; Okura, Masayuki; Peltz, Gerson; Kato, Terufumi 分享 收藏
分享 收藏
Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancer Solomon, Benjamin J.; Bauer, Todd M.; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Liu, Geoffrey; Mazieres, Julien; Kim, Dong-Wan; Mok, Tony; Polli, Anna; Thurm, Holger; Calella, Anna Maria; Peltz, Gerson; Shaw, Alice T. 分享 收藏
Dose modification for the management of CNS adverse events in the phase III CROWN study of lorlatinib in non-small cell lung cancer (NSCLC) Solomon, B. J.; Mok, T. S. K.; Hayashi, H.; Bearz, A.; Penkov, K. D.; Wu, Y-L.; Arrieta, O.; Calella, A. M.; Peltz, G.; Polli, A.; Thurm, H.; Bauer, T. M. 分享 收藏
分享 收藏
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs 洛拉替尼对先前接受第二代ALK TKIs治疗的ALK阳性非小细胞肺癌患者的颅内和颅外疗效 Felip, E.; Shaw, A. T.; Bearz, A.; Camidge, D. R.; Solomon, B. J.; Bauman, J. R.; Bauer, T. M.; Peters, S.; Toffalorio, F.; Abbattista, A.; Thurm, H.; Peltz, G.; Wiltshire, R.; Besse, B. 分享 收藏
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer 一线氯拉替尼或克唑替尼治疗晚期ALK阳性肺癌 Shaw, Alice T.; Bauer, Todd M.; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Liu, Geoffrey; Mazieres, Julien; Kim, Dong-Wan; Mok, Tony; Polli, Anna; Thurm, Holger; Calella, Anna M.; Peltz, Gerson; Solomon, Benjamin J. 分享 收藏
The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants (vol 37, pg 745, 2020) Chen, Joseph; Xu, Huiping; Pawlak, Sylvester; James, Leonard P.; Peltz, Gerson; Lee, Kimberly; Ginman, Katherine; Bergeron, Michelle; Pithavala, Yazdi K. 分享 收藏
Lorlatinib vs crizotinib in the first-line treatment of patients (pts) with advanced ALK-positive non-small cell lung cancer (NSCLC): Results of the phase III CROWN study Solomon, B.; Bauer, T. M.; De Marinis, F.; Felip, E.; Goto, Y.; Liu, G.; Mazieres, J.; Kim, D-W.; Mok, T.; Polli, A.; Thurm, H.; Calella, A. M.; Peltz, G.; Shaw, A. 分享 收藏
Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer Bauer, Todd M.; Shaw, Alice T.; Johnson, Melissa L.; Navarro, Alejandro; Gainor, Justin F.; Thurm, Holger; Pithavala, Yazdi K.; Abbattista, Antonello; Peltz, Gerson; Felip, Enriqueta 分享 收藏
The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants Chen, Joseph; Xu, Huiping; Pawlak, Sylvester; James, Leonard P.; Peltz, Gerson; Lee, Kimberly; Ginman, Katherine; Bergeron, Michelle; Pithavala, Yazdi K. 分享 收藏
分享 收藏
Prospective Observational Comparison of Clinical Outcomes Between African-American and Caucasian Patients Receiving Second-Line Treatment With Pemetrexed for Advanced Non-Small-Cell Lung Cancer Pennella, Eduardo; Obasaju, Coleman K.; Pohl, Gerhardt; Peltz, Gerson; Girvan, Allicia C.; Winfree, Katherine B.; Martinez, Betzaida; Marciniak, Martin; Walker, Mark S.; Stepanski, Edward; Schwartzberg, Lee S.; Adjei, Alex 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
